About CRNX Dividend Returns
Crinetics Pharmaceuticals, Inc. (CRNX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of CRNX over the past year?
Crinetics Pharmaceuticals, Inc. (CRNX) delivered a return of 14.87% over the past year. Since CRNX does not currently pay dividends, the total return equals the price-only return.
Q2How much would $10,000 invested in CRNX be worth today?
A $10,000 investment in Crinetics Pharmaceuticals, Inc. one year ago would be worth $11,487 today, representing a gain of $1,487.
Q3Does CRNX pay dividends?
Crinetics Pharmaceuticals, Inc. (CRNX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For CRNX, the total return equals the price-only return.
Q4Did CRNX beat the S&P 500?
No, Crinetics Pharmaceuticals, Inc. (CRNX) underperformed the S&P 500 by 0.58 percentage points over the past year. CRNX delivered a total return of 14.87%, compared to the S&P 500's 15.45%. This means a passive S&P 500 index fund outperformed CRNX by 0.58pp during this period.
Q5What is CRNX's worst drawdown?
Crinetics Pharmaceuticals, Inc. (CRNX) experienced a maximum drawdown of -28.88% over the past year, declining from its peak on 2025-03-24 to its trough on 2025-04-08. The stock recovered to its prior peak by 2025-09-09. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is CRNX's long-term total return over 10, 20, or 30 years?
Crinetics Pharmaceuticals, Inc. (CRNX) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is 67.7% (5.3% CAGR) — $10,000 would have grown to $16,769. Over 20 years: 67.7% total return (2.6% CAGR) — $10,000 → $16,769. Over 30 years: 67.7% total return (1.7% CAGR) — $10,000 → $16,769. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was CRNX's best and worst year?
Crinetics Pharmaceuticals, Inc.'s best calendar year was 2021 with a total return of 103.7%. Its worst year was 2020 with a total return of -44.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 148.1 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).